Importantly, a related Brca1−/− mouse tumor cell line, which acquired olaparib resistance as a result of 53BP1 inactivation (Jaspers et al, 2013), also showed remarkable sensitivity to acetaldehyde in viability assays (Fig 6B). This evidence concerns the gene TP53BP1 and neoplasm.